Lipidated tlr7 / 8 modulators as adjuvants and uses thereof

TW202635661APending Publication Date: 2026-09-01PFIZER INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141058
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-09-23
Filing Date
2025-10-23
Publication Date
2026-09-01
Patent Text Reader

Abstract

The disclosure relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein X1, X2, and Y are as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The compounds of Formula (I) may modulate the activity of antigens of interest and may be useful in inducing or enhancing an immune response against diseases, disorders and conditions mediated by antigens of interest. In a particular embodiment, the compounds of Formula (I) may be useful as a component of a liposomal adjuvant formulation.
Need to check novelty before this filing date? Find Prior Art